search
Back to results

Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)

Primary Purpose

Chronic Sinusitis

Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Sinuplasty
Sponsored by
Acclarent
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Sinusitis focused on measuring sinusitis, rhinitis, sinus surgery, maxillary, ethmoid, sphenoid, frontal, FESS, sinuplasty

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age 18 years and greater Both male and female patients eligible Diagnosis of chronic sinusitis that is not responsive to medical management Planned endoscopic sinus surgery (recommended by PI, consented to by patient) Exclusion Criteria: Extensive sinonasal polyps Extensive previous sinonasal surgery Extensive sinonasal osteoneogenesis Cystic fibrosis Sampter's Triad (Aspirin sensitivity, Asthma, Sinonasal polyposis) Sinonasal tumors or obstructive lesions History of facial trauma that distorts sinus anatomy and precludes access to the sinus ostium Ciliary dysfunction Pregnant females

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Number of Sinuses With Patency of Sinus Ostium After Sinuplasty
    Patency of sinus ostium after sinuplasty will be determined by nasal endoscopic examination. The investigator will make a clinical judgment as to whether or not this has been achieved.
    Number of Participants With Adverse Events Following Sinuplasty Procedure
    Adverse event rate at 24 weeks: comprised of all observed peri-operative adverse events which were recorded on dedicated CRFs and any observed or patient-reported post-operative adverse events will be similarly recorded (through 24 week follow-up).

    Secondary Outcome Measures

    Number of Participants Experiencing Relief of Sinus Symptoms
    To gain general insight into the ability of balloon catheter sinus ostial dilation to relieve sinus symptoms, scores from the pre-operative SNOT-20 evaluations were compared to scores from the post-procedure SNOT-20 evaluations at 24 weeks following the procedure. The number of participants who showed aggregate symptom relief are recorded here as having been successfully treated.

    Full Information

    First Posted
    September 30, 2005
    Last Updated
    June 10, 2011
    Sponsor
    Acclarent
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00231062
    Brief Title
    Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)
    Official Title
    Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2011
    Overall Recruitment Status
    Completed
    Study Start Date
    April 2005 (undefined)
    Primary Completion Date
    June 2006 (Actual)
    Study Completion Date
    June 2006 (Actual)

    3. Sponsor/Collaborators

    Name of the Sponsor
    Acclarent

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    A multi-center, non-randomized, prospective post-market evaluation of sinuplasty in paranasal sinuses.
    Detailed Description
    Sinusitis is a common healthcare problem that significantly reduces quality of life for people around the world. Patients suffer from headache, facial discomfort, nasal congestion, nasal drainage, loss of the sense of smell and malaise. Sinusitis is responsible for major healthcare expenditure and loss of workplace productivity. The rationale of this study is to collect data on the effectiveness and safety of balloon dilation of the Frontal, Maxillary and Sphenoid sinuses by treating patients and observing them for a six month period of time following the procedure. Six month follow-up data is important to demonstrate the effectiveness of balloon catheter dilation.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Chronic Sinusitis
    Keywords
    sinusitis, rhinitis, sinus surgery, maxillary, ethmoid, sphenoid, frontal, FESS, sinuplasty

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    115 (Actual)

    8. Arms, Groups, and Interventions

    Intervention Type
    Device
    Intervention Name(s)
    Sinuplasty
    Primary Outcome Measure Information:
    Title
    Number of Sinuses With Patency of Sinus Ostium After Sinuplasty
    Description
    Patency of sinus ostium after sinuplasty will be determined by nasal endoscopic examination. The investigator will make a clinical judgment as to whether or not this has been achieved.
    Time Frame
    24 weeks
    Title
    Number of Participants With Adverse Events Following Sinuplasty Procedure
    Description
    Adverse event rate at 24 weeks: comprised of all observed peri-operative adverse events which were recorded on dedicated CRFs and any observed or patient-reported post-operative adverse events will be similarly recorded (through 24 week follow-up).
    Time Frame
    24 weeks
    Secondary Outcome Measure Information:
    Title
    Number of Participants Experiencing Relief of Sinus Symptoms
    Description
    To gain general insight into the ability of balloon catheter sinus ostial dilation to relieve sinus symptoms, scores from the pre-operative SNOT-20 evaluations were compared to scores from the post-procedure SNOT-20 evaluations at 24 weeks following the procedure. The number of participants who showed aggregate symptom relief are recorded here as having been successfully treated.
    Time Frame
    Week 24

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Age 18 years and greater Both male and female patients eligible Diagnosis of chronic sinusitis that is not responsive to medical management Planned endoscopic sinus surgery (recommended by PI, consented to by patient) Exclusion Criteria: Extensive sinonasal polyps Extensive previous sinonasal surgery Extensive sinonasal osteoneogenesis Cystic fibrosis Sampter's Triad (Aspirin sensitivity, Asthma, Sinonasal polyposis) Sinonasal tumors or obstructive lesions History of facial trauma that distorts sinus anatomy and precludes access to the sinus ostium Ciliary dysfunction Pregnant females
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Christopher Church, MD
    Organizational Affiliation
    Loma Linda University
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR)

    We'll reach out to this number within 24 hrs